Shareholder Alert: Ademi LLP investigates whether Transphorm, Inc. has obtained a Fair Price in its transaction with Renesas

Provided By PR Newswire

Last update: Jan 11, 2024

MILWAUKEE, Jan. 11, 2024 /PRNewswire/ -- Ademi LLP is investigating Transphorm (Nasdaq: TGAN) for possible breaches of fiduciary duty and other violations of law in its transaction with Renesas.